Weiluo Cai
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Sarcoma Diagnosis and Treatment 5
- Ferroptosis and cancer prognosis 1
- Surgery 5
- Management of metastatic bone disease 3
- Orthopaedic implants and arthroplasty 2
- Co-authors
- Wending Huang (17 shared papers)Wangjun Yan (20 shared papers)Mo Cheng (15 shared papers)Chunmeng Wang (7 shared papers)Wangjun Yan (3 shared papers)Jianru Xiao (2 shared papers)Tianrui Chen (2 shared papers)Yanmei Wu (1 shared paper)
- Journals
- FEBS Open Bio (2 papers)Cancer Management and Research (2 papers)European Journal of Pharmacology (1 paper)Computers in Biology and Medicine (1 paper)ACS Biomaterials Science & Engineering (1 paper)
- Partner nations
- ChinaUnited StatesQatar
In The Last Decade
Weiluo Cai
23 papers receiving 476 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 91
- Oncology 95
- Pulmonary and Respiratory Medicine 105
- Biomaterials 37
- Biomedical Engineering 86
Countries citing papers authored by Weiluo Cai
This map shows the geographic impact of Weiluo Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiluo Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiluo Cai more than expected).
Fields of papers citing papers by Weiluo Cai
This network shows the impact of papers produced by Weiluo Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiluo Cai. The network helps show where Weiluo Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiluo Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 104 | |
| 2 | 2023 | 83 | |
| 3 | 2020 | 44 | |
| 4 | 2019 | 43 | |
| 5 | 2018 | 21 | |
| 6 | 2018 | 20 | |
| 7 | 2018 | 19 | |
| 8 | 2022 | 18 | |
| 9 | 2019 | 17 | |
| 10 | 2022 | 14 | |
| 11 | 2023 | 13 | |
| 12 | 2024 | 11 | |
| 13 | 2018 | 10 | |
| 14 | 2019 | 9 | |
| 15 | 2021 | 9 | |
| 16 | 2023 | 9 | |
| 17 | 2014 | 7 | |
| 18 | 2020 | 7 | |
| 19 | 2016 | 6 | |
| 20 | 2019 | 5 |
About Weiluo Cai
Weiluo Cai is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Biomedical Engineering and Pathology and Forensic Medicine, having authored 27 papers that have together received 478 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (5 papers), Management of metastatic bone disease (3 papers), Nanoplatforms for cancer theranostics (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Spine and Intervertebral Disc Pathology (2 papers), Orthopaedic implants and arthroplasty (2 papers), Ferroptosis and cancer prognosis (1 paper) and Polymer Surface Interaction Studies (1 paper). The work is most often cited by research in Cancer Research (91 citations), Oncology (95 citations), Pulmonary and Respiratory Medicine (105 citations), Biomaterials (37 citations) and Biomedical Engineering (86 citations). Weiluo Cai has collaborated with scholars based in China, United States and Qatar. Frequent co-authors include Wending Huang, Wangjun Yan, Mo Cheng, Chunmeng Wang, Wangjun Yan, Jianru Xiao, Tianrui Chen, Yanmei Wu, Hengyu Li and Chenglong Zhao. Their work appears in journals such as FEBS Open Bio, Cancer Management and Research, European Journal of Pharmacology, Computers in Biology and Medicine and ACS Biomaterials Science & Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.